alexa Generic Vs. Branded Medicines: A Wide Gap In Curriculum And Clinical Practice
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

Meena Shelgaonkar
Accepted Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.015
Pharmacology lectures and learning chemical names of medicines is often boring and exhausting but medical students have to learn it as a basis of therapeutics. However when it comes to clinical practice, pharmaceutical companies bombard them with brand names with attractive literature and lucrative gestures. Over a period augmentin becomes more efficient than amoxiciilin clauvunate. Of course patients ultimately have to pay for these medicinal branding. Now patient care cost is becoming a social problem for everybody including govt. agencies and private sector. At CIIMS Nagpur , a neurospeciality trust hospital, we conducted various studies to bridge this gap in generic and branded medicines successfully which led to better infection control, reduction in hospital stay and patient care costs with good inventory control and hospital profit.
Meena Shelgaonkar has completed her PhD at the age of 48 years GMCH and PGDT Nagpur University from Maharashtra. She is a patent holder of? A new treatment for tuberculosis- based on PhD research work in clinical pharmacology from 2003. Now, she is working as Director of Phytabolites Neutraceuticals Pvt. Ltd. Nasik and as Clinical Pharmacologist Consultant at Central India Institute of Medical Sciences, Nagpur a premier neuro-speciality hospital in central India, mainly looking after patient care. She has published two books; one on hospital and clinical pharmacy for pharmacy students and another on IPR. She served as technical head -CRO for Pharma company.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version